Bile Acid Ratio in Diagnosis of Intrahepatic Cholestasis of Pregnancy

ABSTRACT

We sought to determine if the bile acid ratio of cholic acid to chenodeoxycholic acid (CA:CDCA) is an important component for diagnosis of intrahepatic cholestasis of pregnancy (ICP). We assessed the addition of bile acid CA:CDCA ratio information in diagnosing ICP in a database of patients evaluated for ICP by serum bile acids and hepatic transaminases. Patients were considered to test positive for ICP if there was elevation in total bile acid, CA:CDCA ratio, or transaminase. Of 231 specimens evaluated for ICP with bile acid and transaminases, 17.1% had elevated total bile acids, 29.4% had elevated transaminase, and 8.2% had an elevated bile acid ratio. Most specimens with elevated bile acid ratio also had elevated total bile acid; 35.5% of specimens tested positive by total bile acid and/or transaminases, increasing minimally to 35.9% with bile acid ratio information. Similar results were found using lower total bile acid and bile acid ratio thresholds. The bile acid CA:CDCA ratio contributed little to the diagnosis of ICP. The use of total bile acid and hepatic transaminases without bile acid ratios decreased positive tests by less than 2%.

Bile acid - cholestasis of pregnancy - diagnosis - intrahepatic cholestasis

REFERENCES

• 1 Brites D, Rodrigues C M, Oliveira N, Cardoso M, Graca L M. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.  J Hepatol. 1998;  28 91-98
• 2 Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy.  Obstet Gynecol. 1983;  61 581-587
• 3 Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.  Ann Hepatol. 2002;  1 20-28
• 4 Caughey A B. Cholestasis of pregnancy: in need of a more rapid diagnosis [comment].  J Perinatol. 2006;  26 525-526
• 5 Glantz A, Marschall H U, Mattsson L A. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates [see comment].  Hepatology. 2004;  40 467-474
• 6 Huang W M, Seubert D E, Donnelly J G, Liu M, Javitt N B. Intrahepatic cholestasis of pregnancy: detection with urinary bile acid assays.  J Perinat Med. 2007;  35 486-491
• 7 Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A. Obstetric cholestasis: outcome with active management.  Eur J Obstet Gynecol Reprod Biol. 2002;  100 167-170
• 8 Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.  J Perinat Med. 2006;  34 383-391
• 9 Ye L, Liu S, Wang M, Shao Y, Ding M. High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy.  J Chromatogr B Analyt Technol Biomed Life Sci. 2007;  860 10-17
• 10 Nakamura K, Yoneda M, Kimura A et al.. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.  J Gastroenterol Hepatol. 1996;  11 385-390